Search

Home > New FDA Approvals > 090 - Osmolex ER for Parkinson’s; FDA advisors reject new use for nerve block; New guidance from FDA for Alzheimer’s research
Podcast: New FDA Approvals
Episode:

090 - Osmolex ER for Parkinson’s; FDA advisors reject new use for nerve block; New guidance from FDA for Alzheimer’s research
Category: Science & Medicine
Duration: 00:08:48
Publish Date: 2018-02-20 07:00:00
Description:

February 20, 2018

Please subscribe, rate and review! The podcast website is http://newfdaapprovals.com

1:24 FDA approves amantadine extended release for Parkinson's movement disorders http://www.osmotica.com/PDF/Osmotica_Release_2_19_18_FINAL.pdf 

2:47 FDA advisors reject new use for Pacira nerve block https://pharmaphorum.com/news/fda-advisers-reject-new-use-pacira-nerve-block/ 

4:32 FDA floats new rules for testing Alzheimer's drugs http://www.sciencemag.org/news/2018/02/fda-floats-new-rules-testing-alzheimers-drugs

Brought to you by Nascent Medical, http://www.nascentmc.com

Music credit: http://freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0